In this study, we investigated whether CBD overcomes oxaliplatin resistance in CRC cells, and the relationship between NOS3 downregulation and combined oxaliplatin and CBD treatment-induced autophagy. The gene discussed is NOS3; the disease is colorectal carcinoma.